Business Wire

Horizon3.ai Gains FedRAMP High Authorization, Delivering on Its Commitment to Secure the Public Sector

Share

Horizon3.ai, the global leader in offensive security, today announced it has gained Federal Risk and Authorization Management Program (FedRAMP®) High Authorization, unlocking the ability to support even the most security-sensitive federal missions. This milestone fulfills Horizon3.ai’s previously announced commitment to bring proof-based security to government agencies operating at the highest levels of compliance and risk exposure.

Horizon3.ai’s newly authorized platform, NodeZero Federal™, is now available to federal agencies under the FedRAMP High baseline. Built upon the proven commercial version of the NodeZero® Offensive Security Platform, NodeZero Federal™ is designed specifically to meet the heightened security and compliance demands of government environments. With this authorization in place, Horizon3.ai becomes the first and only cybersecurity vendor authorized to deliver continuous, autonomous pentesting within this strict regulatory framework.

“We built NodeZero to help defenders find and fix vulnerabilities before attackers exploit them—and with the FedRAMP High authorization, we’re now able to proactively secure critical federal systems,” said Snehal Antani, CEO and Co-founder of Horizon3.ai. “Our roots are in National Security, and with cyber warfare evolving at an unprecedented pace, we’re committed to improving the cyber resilience of the nation’s digital infrastructure, with support for Secret and Top Secret systems as our next major focus areas.”

This authorization builds on Horizon3.ai’s success with Federal partners, such as the NSA Cybersecurity Collaboration Center (CCC) program. As part of CCC, Horizon3.ai powers the NSA’s Continuous Autonomous Penetration Testing (CAPT) program, where Defense Industrial Base (DIB) suppliers use NodeZero to act as nation-state-level adversaries, identify and prioritize real attack paths, and continuously validate their defenses.

“With our FedRAMP High authorization, critical suppliers and federal agencies can verify and improve their cybersecurity posture, ensuring that limited resources are focused on fixing problems that truly matter," said Matt Hartley, CRO at Horizon3.ai. "These agencies can find, fix, and verify the remediation of CISA Known Exploitable Vulnerabilities (KEV) at scale, ensure their security operations center is effectively detecting and stifling attacks, and that security tools are tuned correctly. Offense drives defense, and no one knows this better than our US Federal customers.”

NodeZero Federal helps agencies streamline compliance with key cybersecurity mandates, including NIST SP 800-53—the foundational control framework behind FedRAMP—as well as evolving OMB policies and Executive Orders that require Zero Trust architecture, Cybersecurity Maturity Model Certification (CMMC) 2.0 for supply chain assurance, and participation in Continuous Diagnostics and Mitigation (CDM) programs.

For more information about Horizon3.ai’s NodeZero Federal™ and its FedRAMP High capabilities, visit their website.

About Horizon3.ai

The NodeZero® Offensive Security Platform by Horizon3.ai drives continuous exposure management across production infrastructure. With NodeZero, customers overcome barriers of limited security talent and infrequent, expensive penetration testing. They stay ahead of a rapidly-evolving threat landscape with autonomous pentesting, emerging threat intelligence, threat detection, and unified data and reporting. Founded in 2019 by former industry leaders and U.S. National Security veterans, Horizon3.ai solves diverse use cases across all industries.

Follow Horizon3.ai on LinkedIn and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250515365494/en/

Contacts

Media:
Ed Kraft
SourceCode Communications
horizon3@sourcecodecomms.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 23:51:00 EEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin

Incyte Announces FDA Approval of Zynyz ® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 21:30:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508024371/en/ Zynyz logo "The FDA approval of Zynyz marks a pivotal moment, bringing effective combination and monotherapy treatment options to patients with advanced anal cancer after decades of limited innovation," said Hervé Hoppenot,

DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 21:23:00 EEST | Press release

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational Highlights Revenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit mar

Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 21:18:00 EEST | Press release

Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-class leisure facilities, combined with a surge in real estate revenue, are creating opportunities for investors, driv

Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 21:00:00 EEST | Press release

Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye